Yunfei Wang

发表

Nucleotide Excision Repair Pathway Genes and Oral Premalignant Lesions

M. Spitz, S. Lippman, Xifeng Wu, 2007, Clinical Cancer Research.

The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB.

Ming Sun, Wei Li, Yunfei Wang, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression

Ming Sun, W. De, Zhaoxia Wang, 2016, Oncotarget.

Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk

M. Spitz, Xifeng Wu, H. Grossman, 2005, Cancer Epidemiology Biomarkers & Prevention.

Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study.

M. Spitz, Xifeng Wu, M. Schabath, 2003, Lung cancer.

Histone deacetylases 3 ( HDAC 3 ) is highly expressed in cervical cancer and inhibited by siRNA

Yunfei Wang, Li Zhang, Shuping Zhao, 2016 .

Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis.

M. Spitz, Xifeng Wu, Kerang Zhang, 2002, Lung cancer.

CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling

A. Jazaeri, R. Başar, P. Hwu, 2022, Journal for ImmunoTherapy of Cancer.

Matrix metalloproteinase polymorphisms and bladder cancer risk.

J. Gu, Xifeng Wu, H. Grossman, 2006, Cancer research.

Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors

Yiwen Chen, Nidhi Sahni, Yumei Li, 2022, NAR cancer.

MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic

F. Slack, A. Kasinski, Haifa Shen, 2021, Frontiers in Cell and Developmental Biology.

Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.

Dong Liang, Jian Gu, Xifeng Wu, 2005, Mutation research.

The Emerging Function and Mechanism of ceRNAs in Cancer.

Yonghao Yu, Yiwen Chen, Yiwen Chen, 2016, Trends in genetics : TIG.

CRISPR/CAS9-based DNA damage response screens reveal gene-drug interactions.

Junjie Chen, Chunchao Zhang, Traver Hart, 2020, DNA repair.

Systematic functional interrogation of human pseudogenes using CRISPRi

C. Hon, Yiwen Chen, Han Liang, 2021, Genome Biology.

LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.

Ming Sun, W. De, Zhaoxia Wang, 2016, Cancer research.

Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer.

Ming Sun, Zhaoxia Wang, Yunfei Wang, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

An association between a NQO1 genetic polymorphism and risk of lung cancer.

M. Spitz, Xifeng Wu, Jie Lin, 2005, Mutation research.

XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations

M. Spitz, Xifeng Wu, C. Amos, 2003, Cancer.

18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer

Jing Wang, I. Wistuba, J. Lee, 2020, Cancer Immunology, Immunotherapy.

Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.

R. Millikan, J. Gu, Xifeng Wu, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Functional Polymorphism in RGS6 Modulates the Risk of Bladder Cancer

L. Liotta, Xifeng Wu, Q. Dong, 2004, Cancer Research.

A Functional Polymorphism in RGS 6 Modulates the Risk of Bladder Cancer

L. Liotta, Xifeng Wu, Q. Dong, 2004 .

Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage

C. Kang, Yunfei Wang, Junhu Zhou, 2021, Frontiers in Oncology.

From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity.

M. Spitz, S. Shete, Xifeng Wu, 2003, DNA repair.

Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer

Sean M. Hartig, Yiwen Chen, F. Sicheri, 2018, The Journal of clinical investigation.

Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.

M. Spitz, Xifeng Wu, I. Gorlov, 2004, Carcinogenesis.

Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study.

Xifeng Wu, M. Schabath, Leizhen Zheng, 2003, Cancer letters.

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

Jian Gu, Jie Lin, Xifeng Wu, 2007, Clinical Cancer Research.

Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness.

J. Gu, Xifeng Wu, H. Grossman, 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.

Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators

Yiwen Chen, P. Hwu, C. Yee, 2021, Journal for ImmunoTherapy of Cancer.

Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration

Gengsheng Mao, Yunfei Wang, Jun-hua Huang, 2022, Journal of medical biochemistry.

Inhibiting Type I arginine methyltransferase activity promotes the T cell mediated antitumor immune response.

Guangchun Han, P. Hwu, Linghua Wang, 2022, Cancer immunology research.

Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.

C I Amos, M. Spitz, S. Shete, 2001, Cancer research.